This information has been prepared by Schulte Roth & Zabel LLP ("SRZ") for general informational purposes only, it does not constitute legal advice, and is presented without any representation or warranty as to its accuracy, completeness or timeliness.
Transmission or receipt of this information does not create an attorney-client relationship with SRZ. Electronic mail or other communications with SRZ cannot be guaranteed to be confidential and will not (without SRZ agreement) create an attorney-client relationship with SRZ. Parties seeking advice should consult with legal counsel familiar with their particular circumstances.
Links to other sites are for your convenience only and SRZ does not take any responsibility for those sites, nor does SRZ make any representation or warranty whatsoever with respect to those sites. Under the rules or regulations of some jurisdictions this material may constitute advertising.
-
Resource Centers
Key Shareholder Activism Campaigns
October 2018
Schulte Represents Trian Partners in Proxy Contest for Board Seat at Procter & Gamble Schulte Achieves Unprecedented Victory in Securing Board Seats for venBio and Unwinding Transaction at ImmunomedicsGreenlight Capital Proposes Plan to Unlock... -
Resource Centers
Other Shareholder Activism Resources
October 2018
13D Monitor — Research Service Specializing in Shareholder Activism and 13D FilingsActivist InsightHarvard Law School Forum on Corporate Governance and Financial RegulationThe Official Activist Investing Blog -
Resource Centers
Schulte’s Shareholder Activism Practice in the News
October 2018
“Activist Investors Are Gearing Up for More Battles in the Year Ahead, Taking Aim at Consumer Stocks,” CNBC, Oct. 8, 2018 “Shaping the Future of Shareholder Activism: An Investigation of 2018 Activist Trends,” Forbes, Sept. 12, 2018 “INSIGHT:... -